Human Metaverse Medicine graduate ＆ postdoctoral education programs

We will launch educational programs to foster researchers with advanced expertise in “Human Metaverse Medicine” and to widely and globally expand “Human Metaverse Medicine”. We will develop the next generation of researchers who will realize the concept of this center, spread the idea to the world and other research fields, and further develop interdisciplinary research.

Education Program Outline

In the environment created by this center, we will foster the next generation of researchers with advanced expertise in ”Human Metaverse Medicine” and simultaneously with a bird’s-eye view of the entire field. We expect them to spread the next-generation ”Human Metaverse Medicine” more widely worldwide. In addition, it is necessary to create a foundation for ”Human Metaverse Medicine” to broadly impact many academic fields and develop in collaboration with other areas. To this end, we will promote educational programs from the following two perspectives.

The first is to foster researchers with advanced expertise in ”Human Metaverse Medicine”. Aiming to establish a Graduate Degree Program, “Human Metaverse Medicine,” and a double degree program, we will build educational programs step by step. We will also develop postdoctoral and advanced postdoctoral programs to train young researchers.

The second is to provide research and educational programs to widely and globally expand “Human Metaverse Medicine.” We will offer research and educational programs built within the center to graduate students and young researchers in any field outside the center. In this way, we will foster the foundation for “Human Metaverse Medicine” to broadly impact many academic disciplines and develop multidisciplinary collaboration.

Since I have been involved in graduate school education, including the WISE program and Campus Asia Program/Double Degree Program, I will be responsible for formulating educational programs for this center. From a researcher’s standpoint, I will contribute to developing education-related programs. As a researcher, I have been involved in molecularly identifying biological membrane transporters, analysis of their pathological relevance, and drug discovery research targeting them (references below). Upon our recent finding of a transporter controlling amino acid signals involved in organogenesis, I would also like to contribute to organoid research from the perspective of transporter research.

References

1. Kanai et al. Primary structure and functional characterization of a high-affinity glutamate transporter. Nature 360: 467 (1992)
2. Enomoto et al. Molecular identification of a renal urate anion exchanger that regulates blood urate levels. Nature 417: 447 (2002)
3. Kleta et al. Mutations in SLC6A19, encoding B⁰AT1, cause Hartnup disorder. Nat Genet 36: 999 (2004)
4. Nagamori et al Novel cystine transporter in renal proximal tubule identified as a missing partner of rBAT/SLC3A1. PNAS 113: 775 (2016)
5. Lee et al. Cryo-EM structure of the human L-type amino acid transporter 1. Nat Struct Mol Biol. 26: 510 (2019)
6. Kato et al. Structural insights into inhibitory mechanism of human excitatory amino acid transporter EAAT2. Nat Commun 13: 4714 (2022)
7. Kanai. Amino acid transporter LAT1 as a molecular target for cancer diagnosis and therapeutics. Pharmacol Ther 230:107964 (2022)